JAMES R HESS
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism HAUPPAUGE, NY NPI 1124092747
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism NY Novo Nordisk AS All categories
General Payments — all program years on this page
$8,585.27
- Category: General Payments
- Program years: PY2018–2024
- Record count: 416
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,896.36 across 79 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,896.36 | 79 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $325.58 | 16 |
| Lilly USA, LLC | $239.15 | 10 |
| Amneal Pharmaceuticals LLC | $172.60 | 8 |
| Antares Pharma, Inc. | $126.23 | 4 |
| Xeris Pharmaceuticals, Inc. | $110.57 | 5 |
| Insulet Corporation | $101.55 | 5 |
| SANOFI-AVENTIS U.S. LLC | $97.85 | 4 |
| Medtronic, Inc. | $63.75 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $60.40 | 2 |
| ABBVIE INC. | $52.29 | 2 |
| Relypsa, Inc. | $49.11 | 2 |
| KVK-Tech, Inc. | $49.08 | 1 |
| Radius Health, Inc. | $48.32 | 2 |
| Amgen Inc. | $45.35 | 2 |
| Tandem Diabetes Care, Inc. | $42.32 | 2 |
| Regeneron Healthcare Solutions, Inc. | $41.94 | 2 |
| BAXTER HEALTHCARE | $38.49 | 1 |
| Corcept Therapeutics | $35.83 | 2 |
| GENZYME CORPORATION | $32.70 | 1 |
| ANI Pharmaceuticals, Inc. | $32.61 | 1 |
| HARMONY BIOSCIENCES LLC | $30.53 | 1 |
| DEXCOM, INC. | $24.49 | 1 |
| VIVUS LLC | $20.54 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $20.00 | 1 |
| Abbott Laboratories | $17.96 | 1 |
| Madrigal Pharmaceuticals | $17.12 | 1 |
By program year
Records — PY2024 (79)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.